Table 3. COVID-19 Severity by Receipt of Additional Prostate Cancer Therapies.
| COVID-19 severity ordinal scale | No. (%) of patients | ||
|---|---|---|---|
| ADT alone | ADT with additional therapy | ADT missing data on additional therapy | |
| ARI-1 or ARI-2 (N = 266) | |||
| No. | 120 | 79 | 67 |
| 0 (Uncomplicated) | 46 (38) | 27 (34) | 11 (16) |
| 1 (Hospitalized) | 37 (31) | 27 (34) | 27 (40) |
| 2 (ICU) | 3 (2) | 5 (6) | 21 (31) |
| 3 (Mechanical ventilation) | 7 (6) | 5 (6) | 0 (0) |
| 4 (Death within 30 d) | 22 (18) | 13 (16) | 11 (16) |
| Unknown or missing | 5 (4) | 2 (2) | 5 (7) |
| Abiraterone in combination with prednisone (N = 266) | |||
| No. | 157 | 42 | 67 |
| 0 (Uncomplicated) | 60 (38) | 13 (31) | 27 (40) |
| 1 (Hospitalized) | 48 (31) | 16 (38) | 21 (31) |
| 2 (ICU) | 7 (4) | 1 (2) | 0 (0) |
| 3 (Mechanical ventilation) | 9 (6) | 3 (7) | 3 (4) |
| 4 (Death within 30 d) | 28 (18) | 7 (17) | 1 (16) |
| Unknown or missing | 5 (4) | 2 (5) | 5 (7) |
| Chemotherapy (N = 266) | |||
| No. | 174 | 25 | 67 |
| 0 (Uncomplicated) | 65 (37) | 8 (32) | 27 (40) |
| 1 (Hospitalized) | 58 (33) | 6 (24) | 21 (31) |
| 2 (ICU) | 7 (4) | 1 (4) | 0 (0) |
| 3 (Mechanical ventilation | 9 (5) | 3 (12) | 3 (4) |
| 4 (Death within 30 d) | 28 (16) | 7 (28) | 11 (16) |
| Unknown or missing | 7 (4) | 0 (0) | 5 (7) |
Abbreviations: ADT, androgen deprivation therapy; ARI, androgen receptor inhibitor; ICU, intensive care unit.